A Bertasso

648 citations

22 papers · 447 indexed · h-index 14

Impact in

Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Hepatology top 5%
- Hepatitis C virus research

Papers in ⓘ

Molecular Biology 8
- Cancer therapeutics and mechanisms 6
Infectious Diseases 6
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 2

Co-authors: N H Georgopapadakou (9 shared papers)John Pace (2 shared papers)Jack Chapman (3 shared papers)Andrea Baker (1 shared paper)Willi Kreis (1 shared paper)Stefan Zeuzem (2 shared papers)R. Alten (1 shared paper)Cristiano A. F. Zerbini (1 shared paper)
Journals: Antimicrobial Agents and Chemotherapy (8 papers)Journal of Hepatology (2 papers)The Pediatric Infectious Disease Journal (2 papers)Liver International (1 paper)HIV Medicine (1 paper)
Partner nations: United States United Kingdom Switzerland

In The Last Decade

A Bertasso

22 papers receiving 424 citations

Peers

Countries citing papers authored by A Bertasso

Since Specialization

Citations

This map shows the geographic impact of A Bertasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bertasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bertasso more than expected).

Fields of papers citing papers by A Bertasso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Bertasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bertasso. The network helps show where A Bertasso may publish in the future.

Co-authors

The 25 scholars most cited alongside A Bertasso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Bertasso Line = papers co-authored together A Bertasso links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial HIV Clinical Trials ·M. Rodríguez‐Torres, Jihad Slim, Laveeza Bhatti, Richard K. Sterling, Mark Sulkowski, Tarek Hassanein, Rosário Serrão, Ricard Solà, A Bertasso, and Sharon Passe, Saray Stancic	2012	49
2	Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy Annals of the Rheumatic Diseases ·R. Alten, Cristiano A. F. Zerbini, Sławomir Jeka, Fedra Irazoque, F. Khatib, Paul Emery, A Bertasso, Michael Rabbia, J P Caulfield	2009	49
3	1412 INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS Journal of Hepatology ·Edward Gane, Paul J. Pockros, Stefan Zeuzem, Patrick Marcellin, Anna Shikhman, Coen Bernaards, Ellen S. Yetzer, Nancy S. Shulman, Xiao Tong, Isabel Nájera, A Bertasso, Jennifer Hammond, Saray Stancic	2012	47
4	Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus Antimicrobial Agents and Chemotherapy ·Catherine McCaffrey, A Bertasso, John Pace, N H Georgopapadakou	1992	35
5	Mode of action of the dual-action cephalosporin Ro 23-9424 Antimicrobial Agents and Chemotherapy ·N H Georgopapadakou, A Bertasso, K.‐K. CHAN, Jack Chapman, Roy Cleeland, Leda M. Cummings, B A Dix, Dennis D. Keith	1989	35
6	Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture. PubMed ·Willi Kreis, Andrea Baker, Valerie Ryan, A Bertasso	1980	31
7	Effects of squalene epoxidase inhibitors on Candida albicans Antimicrobial Agents and Chemotherapy ·N H Georgopapadakou, A Bertasso	1992	24
8	Mericitabine and ritonavir‐boosted danoprevir with or without ribavirin in treatment‐naive HCV genotype 1 patients: INFORM ‐ SVR study Liver International ·Edward Gane, Paul J. Pockros, Stefan Zeuzem, Patrick Marcellin, Anna Shikhman, Coen Bernaards, Julian Q. Zhou, Ellen S. Yetzer, R. Ballester, Cindy Dwyer, Xiao Tong, Isabel Nájera, A Bertasso, Janet Hammond, Amy V. Kindrick, Peter N. Morcos, Patrick F. Smith, Saray Stancic, Nancy S. Shulman	2014	23
9	Pharmacokinetics of Enfuvirtide in Pediatric Human Immunodeficiency Virus 1-Infected Patients Receiving Combination Therapy The Pediatric Infectious Disease Journal ·S. Eralp Bellibas, Zikia Siddique, Albert Dorr, A Bertasso, Prakash Sista, Stanley J. Kolis, S. Cotler, Patricia DeLora	2004	20
10	Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli Antimicrobial Agents and Chemotherapy ·N H Georgopapadakou, A Bertasso	1993	20
11	Safety and Efficacy of Enfuvirtide for 48 Weeks as Part of an Optimized Antiretroviral Regimen in Pediatric Human Immunodeficiency Virus 1-Infected Patients The Pediatric Infectious Disease Journal ·Andrew Wiznia, Joseph A. Church, Patricia Emmanuel, Stephen C. Eppes, Lucy Rowell, Claire F. Evans, A Bertasso	2007	17
12	Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424 Antimicrobial Agents and Chemotherapy ·John Pace, A Bertasso, N H Georgopapadakou	1991	16
13	Fleroxacin resistance in Escherichia coli Antimicrobial Agents and Chemotherapy ·Jack Chapman, A Bertasso, N H Georgopapadakou	1989	15
14	Effects of quinolones on nucleoid segregation in Escherichia coli Antimicrobial Agents and Chemotherapy ·N H Georgopapadakou, A Bertasso	1991	14
15	The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy* HIV Medicine ·DA Cooper, DV Cordery, Peter Reiss, Keith Henry, Mark Nelson, Mary O’Hearn, Jacques Reynes, K Arastéh, Jain Chung, Lucy Rowell, Denise Guimaraes, A Bertasso, (unknown)	2010	12
16	Population Pharmacokinetics of Enfuvirtide in HIV‐1‐Infected Pediatric Patients Over 48 Weeks of Treatment The Journal of Clinical Pharmacology ·Xiaoping Zhang, Tiffany Lin, A Bertasso, Claire F. Evans, Albert Dorr, Stanley J. Kolis, Miklos Salgo, Indravadan H. Patel	2007	11
17	Porins and lipopolysaccharide ofEscherichia coliATCC 25922 and isogenic rough mutants FEMS Microbiology Letters ·Mildred Rivera, A Bertasso, Catherine McCaffrey, Nafsika H. Georgopapadakou	1993	9
18	Screening assays for protein synthesis inhibitors. The Journal of Antibiotics ·Clifford C. Hall, A Bertasso, John D. Watkins, N H Georgopapadakou	1992	8
19	Adherence to Enfuvirtide and Its Impact on Treatment Efficacy AIDS Research and Human Retroviruses ·Jürgen K. Rockstroh, Edwin DeJesus, Lucille Donatacci, Cynthia Wat, A Bertasso, Emily Labriola–Tompkins, Anna Shikhman, Belinda Atkins, Denise Guimaraes, Timothy D. Wilkinson, James Thommes, Lucy Rowell, Ralph DeMasi, Miklos Salgo	2008	4
20	Low-level resistance to the cephalosporin 3'-quinolone ester Ro 23-9424 in Escherichia coli Antimicrobial Agents and Chemotherapy ·Jack Chapman, A Bertasso, Leda M. Cummings, N H Georgopapadakou	1995	4

About A Bertasso

A Bertasso is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Virology and Pharmacology, having authored 22 papers that have together received 447 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer therapeutics and mechanisms (6 papers), HIV/AIDS drug development and treatment (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (5 papers), Hepatitis C virus research (3 papers) and HIV/AIDS Research and Interventions (2 papers). The work is most often cited by research in Molecular Medicine (100 citations), Hepatology (121 citations), Virology (44 citations), Infectious Diseases (143 citations) and Pharmacology (88 citations). A Bertasso has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include N H Georgopapadakou, John Pace, Jack Chapman, Andrea Baker, Willi Kreis, Stefan Zeuzem, R. Alten, Cristiano A. F. Zerbini, Mark Sulkowski and Leda M. Cummings. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology, The Pediatric Infectious Disease Journal, Liver International and HIV Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact